Dr. Eduardo Alpay Tan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 315-751-7747 |
Dr. Anriada Nassif, MD Emergency Medicine - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-697-3300 |
Karen A Stanlaw, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86-260 Farrington Hwy, Waianae Coast Comprehensive Health Center, Waianae, HI 96792 Phone: 920-265-6902 |
Dr. Robert Thomas Bonham, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-7081 Fax: 808-696-7093 |
Dr. Eric C. Nino, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86-260 Farrington Hwy., Waianae, HI 96792 Phone: 808-697-3501 Fax: 808-697-3670 |
Dr. Scott Thomas Padavan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-1501 |
Dr. Jeffrey D Ching, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-7081 Fax: 808-696-7093 |
Dr. Allon Amitai, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-7081 Fax: 808-696-1581 |
Dr. Paul Colm O'hara, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-697-3300 |
Dr. Richard A Price, MD, JD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86-260 Farrington Hwy, Waianae, HI 96792 Phone: 808-696-7081 Fax: 808-696-7093 |
News Archive
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
A team at the University of Rochester has found that the human brain makes much more extensive use of highly complex statistics when learning a language than scientists ever realized.
› Verified 2 days ago